GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography

NCT06223204 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators